CD274 and neoplasm: Expression of PD-L1 on circulating immune cells is unlikely to be useful as a stand-alone biomarker as they are not consistent with those on tumor infiltration immune cells (i.e., TLS only can be found in tumor tissues), and one cannot spatially differentiate tumor-infiltrating PD-L1+ immune cells from tumor cells [272,273].